Researcher Set to Make Breakthrough on IBD
The University of Houston announced that researcher Chandra Mohan is set to make a breakthrough in predicting and monitoring inflammatory bowel disease.
With a grant of $347,490 from the Crohn's & Colitis Foundation of America, he and IBD expert Subra Kugathasan, a gastroenterologist at Emory University, are examining stool protein biomarkers that indicate the disease, the university said. Dr. Kugathasan is a faculty member in the PBEE program.
An autoimmune disease, IBD occurs when the body's immune system fights its intestinal cells. Two of the most common types are Crohn's disease and ulcerative colitis, both of which cause inflammation in the digestive tract.